Oncternal Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Oncternal Therapeutics has a total shareholder equity of $30.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $36.7M and $6.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$34.26m |
Equity | US$30.05m |
Total liabilities | US$6.68m |
Total assets | US$36.73m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: GTU's short term assets ($36.1M) exceed its short term liabilities ($5.2M).
Long Term Liabilities: GTU's short term assets ($36.1M) exceed its long term liabilities ($1.5M).
Debt to Equity History and Analysis
Debt Level: GTU is debt free.
Reducing Debt: GTU had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GTU has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: GTU has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 25.6% each year.